{
}
UBS has maintained a "Neutral" rating for Novo Nordisk, setting a target price of 1100 Danish kroner. Analyst Jo Walton noted a slight increase in first-time prescriptions for weight-loss drugs in the US, based on data up to December 6.
UBS has reduced its target price for Carlsberg A/S to DKK 800 from DKK 870 while maintaining a neutral stance. The company is a major global beer producer, with 101 million hectoliters sold in 2023, primarily under the Carlsberg and Tuborg brands, and operates 71 breweries across various regions. Its net sales are predominantly from Western Europe (50.7%), followed by Asia (31.7%) and Eastern/Central Europe (17.6%).
UBS has reduced its target price for Carlsberg A/S to DKK 800 from DKK 870, maintaining a neutral stance on the company. Carlsberg, a leading global beer producer, sold 101 million hectoliters of beer in 2023, primarily under the Carlsberg and Tuborg brands, and also produced 24.1 million hectoliters of non-alcoholic beverages in 2022. The company operates 71 breweries across various regions, with net sales distributed as follows: Western Europe (50.7%), Asia (31.7%), and Eastern/Central Europe (17.6%).
UBS has reduced its target price for Carlsberg to DKK 800 from DKK 870 while maintaining a neutral stance on the company. Carlsberg A/S, a leading global beer producer, sold 101 million hectoliters of beer in 2023, primarily under the Carlsberg and Tuborg brands, and 24.1 million hectoliters of non-alcoholic beverages. The company's sales are distributed across Western Europe (50.7%), Asia (31.7%), and Eastern and Central Europe (17.6%).
UBS has upgraded Coloplast A/S to a "neutral" rating from "sell," citing improved market dynamics and reduced risks associated with the company's operations. The revision reflects a reassessment of competitive pressures and growth investments, particularly in wound biologics and continence care. Analysts project an 8% compound annual revenue growth rate and an 11% increase in earnings per share from 2024 to 2028, with the stock trading at a 40% sector premium.
UBS has upgraded Coloplast A/S to a "neutral" rating from "sell," citing improved market dynamics and a reassessment of risks. The firm noted reduced competitive pressures and a more conservative market outlook, with expectations of steady growth, projecting an 8% annual revenue increase and an 11% rise in earnings per share from 2024 to 2028. The stock is now trading at a 40% sector premium, aligning with historical averages, and UBS set a price target of DKK 858, reflecting a valuation of 33 times estimated 2025 earnings.
UBS has upgraded Coloplast to a neutral rating while maintaining its price target at DKK 858, citing reduced risks following the recent sale of its skin care business, which led to a 1% cut in sales estimates. The company specializes in disposable medical products, with significant sales in the USA and UK.
UBS has upgraded Coloplast to a neutral rating while maintaining a price target of DKK 858. Coloplast A/S focuses on disposable medical products, with sales divided into hygiene products (43.4%), ostomy care (36.8%), wound and skin care (11.9%), and vocal and respiratory care (7.9%). Geographically, the company generates 1.4% of sales in Denmark, 21% in the USA, 14% in the UK, 10.8% in France, and 52.8% from other regions.
UBS has upgraded Coloplast to a neutral rating while maintaining a price target of DKK 858. The company specializes in disposable medical products, with net sales primarily from hygiene products (43.4%), ostomy care (36.8%), wound and skin care (11.9%), and voice and respiratory care (7.9%). Geographically, sales are distributed with 21% in the U.S., 14% in the U.K., and 10.8% in France, among others.
Denmark's Nykredit has made a DKr24bn ($3.5bn) cash offer to acquire Spar Nord Bank, representing a 49% premium on its share price, with completion expected in the first half of 2025. In other news, AllianceBernstein plans to sue Switzerland over the $17bn writedown of Credit Suisse's AT1 bonds, joining a lawsuit that claims investor rights were violated during the UBS takeover. Additionally, DBS Group, Mitsubishi UFJ Financial Group, and Sumitomo Mitsui Financial Group are potential bidders for Indonesia's Panin Bank, which has seen a significant rise in its share value this year. Morgan Stanley will pay $15mn to settle SEC allegations regarding inadequate fraud prevention measures at its Smith Barney unit.
Danish Krone
Currency
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
UBS Maintains Neutral Rating for Novo Nordisk with Target Price of 1100 Kroner
15:24 16.12.2024
UBS Adjusts Carlsberg Target Price Amidst Global Beer Market Dynamics
10:04 12.12.2024
ubs lowers carlsberg target price amid strong global beer sales
10:04 12.12.2024
UBS Lowers Carlsberg Target Price to DKK 800 Maintaining Neutral Position
10:04 12.12.2024
UBS Upgrades Coloplast to Neutral Amid Improved Market Dynamics and Growth Prospects
15:00 11.12.2024
ubs upgrades coloplast to neutral amid improved market dynamics and growth prospects
15:00 11.12.2024
UBS Upgrades Coloplast to Neutral Following Skin Care Business Sale
10:38 11.12.2024
UBS Upgrades Coloplast to Neutral with Price Target of DKK 858
09:55 11.12.2024
UBS Upgrades Coloplast to Neutral with Price Target of DKK 858
09:55 11.12.2024
Nykredit to Acquire Spar Nord Bank in Major Danish Banking Merger
United States Dollar
Japanese Yen
Danish Krone
Singapore Dollar
AllianceBernstein Holding L.P.
Spar Nord Bank A/S
DBS Group Holdings Ltd
Morgan Stanley
Mitsubishi UFJ Financial Group, Inc.
ANZ Group Holdings Ltd
Sumitomo Mitsui Financial Group, Inc.
Credit Suisse Real Estate Fund Siat
CHE
DNK
USA
AUS
SGP
IDN
JPN
Show more
12:03 10.12.2024
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Banking Regulations
Finance Mergers & Acquisitions
Global Financial Events
Retail and Consumer Goods
CEO Changes
Central Bank Actions
GDP Growth & Recession Forecasts
Global Trade Developments
Market Analysis and Predictions
Industry Mergers & Acquisitions
Financial Scams and Security
Inflation and Monetary Impact
Government Policies
Government Economic Policies
Supply Chain Management
Startups & Entrepreneurship
Workplace Trends
Countries:
Companies:
The Goldman Sachs Group, Inc.
JPMorgan Chase & Co.
Tesla, Inc.
Apple Inc.
Barclays PLC
Bank of America Corporation
Wells Fargo & Company
Citigroup Inc.
Deutsche Bank Money Market PP
Morgan Stanley
Huawei Technologies CO. Ltd.
Lloyds Banking Group plc
Microsoft Corporation
Credit Suisse Strategic Income I
NVIDIA Corporation
Amazon.com, Inc.
AXA SA
Safran SA
Banco Santander, S.A.
Novartis AG
Currencies:
United States Dollar
Euro
Chinese Yuan
British Pound Sterling
Swiss Franc
Japanese Yen
Indian Rupee
Russian Ruble
Australian Dollar
Canadian Dollar
United Arab Emirates Dirham
Indonesian Rupiah
Saudi Riyal
South Korean Won
Danish Krone
Offshore Chinese Yuan
Turkish Lira
Hong Kong Dollar
Mexican Peso
Malaysian Ringgit
People: